Pharmacy

Your Article Summary

See Latest Articles

Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage-gated calcium channel alpha-2-delta subunit
British Journal of Clinical Pharmacology, 08/14/09

Corrigan B et al. – PD 0200390 pharmacokinetic parameters vary predictably with decreases in renal function; therefore dose adjustment may be required in individuals with RI.

Today in Dosing...keeping you current

Receive free subspecialty "5-minute updates" via email

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Risperidone dose for schizophrenia
Cochrane Reviews, 10/21/09

Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09

See All of Dosing

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09

A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09

See All of Other Drugs

Today in Pharmacokinetics...keeping you current

Receive free subspecialty "5-minute updates" via email

U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin Resistant Type 2 Diabetic Patients
Diabetes Care, 11/16/09

The role of ceramide in major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience, 11/12/09

Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09

See All of Pharmacokinetics